Figure 1.
A schematic overview representing exposure to nanomaterials/ -particles (1), aggregated across sources and over time, their absorption and distribution in the body (2), and accumulated outcomes from exposure accumulated across materials and over time at the cellular, organ (3) and individual or population level (4).